BROADWOOD PARTNERS, L.P. 4

What Happened
Broadwood Partners, L.P. (reported as a 10% owner) made open-market purchases of STAAR Surgical (STAA) common stock on March 11–13, 2026. Purchases by date: 54,764 shares at a weighted average $17.52 on Mar 11 (≈ $959,558); 299,432 shares at $18.12 on Mar 12 (≈ $5,424,330); and 316,017 shares at $18.61 on Mar 13 (≈ $5,882,656). Total acquired: 670,213 shares for approximately $12,266,544. Transaction code: P (purchase) — this is an institutional buy rather than an insider sale.

Key Details

• Transaction dates and reported weighted-average prices: Mar 11 (54,764 @ $17.52), Mar 12 (299,432 @ $18.12), Mar 13 (316,017 @ $18.61).
• Total shares acquired: 670,213; total reported value: ≈ $12.27 million.
• Footnotes: F1 notes Broadwood Partners directly owns the securities and they may be indirectly beneficially owned by Broadwood Capital, Inc. and Neal C. Bradsher (who disclaims beneficial ownership except to the extent of pecuniary interest). F2–F4 state the quoted prices are weighted averages and provide per-day price ranges (Mar 11 range $17.18–$17.70; Mar 12 range $17.43–$18.39; Mar 13 range $18.10–$18.84); full per-price breakdowns are available on request. F5 indicates some securities are directly owned by Neal C. Bradsher.
• Shares owned after transaction: not disclosed in the data provided in this summary.
• Filing: Form 4 filed Mar 13, 2026 for trades on Mar 11–13 — appears to be timely under Section 16 reporting (no late-filing flag reported).

Context

• These were open-market institutional purchases by a reported 10% owner, which retail investors often view differently than trades by company insiders/executives. The filing is factual evidence of accumulation but does not state motivation.
• No options, awards, gifts, or sales were reported in this filing — only outright purchases (code P).